Chemiluminiscence detection method and chemiluminiscence detection kit for aspirin metabolism and platelet high reactivity

A chemiluminescent detection and aspirin technology, applied in the field of biological detection, can solve problems such as misleading and incomplete response, and achieve the effect of reducing poor results

Active Publication Date: 2020-10-02
湖南远璟生物技术有限公司
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the drug metabolism disorders or genetic defects that lead to true aspirin "resistance" have not been clarified, and the statement of AR is somewhat misleading. Therefore, high on-aspirin platelet reactivity (HAPR) under aspirin treatme

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chemiluminiscence detection method and chemiluminiscence detection kit for aspirin metabolism and platelet high reactivity
  • Chemiluminiscence detection method and chemiluminiscence detection kit for aspirin metabolism and platelet high reactivity
  • Chemiluminiscence detection method and chemiluminiscence detection kit for aspirin metabolism and platelet high reactivity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0048] The chemiluminescent detection method and detection kit for aspirin metabolism and platelet hyperreactivity provided by the present invention will be further described in detail and completely in conjunction with the examples below. The embodiments described below are exemplary only for explaining the present invention and should not be construed as limiting the present invention.

[0049] The experimental methods in the following examples are conventional methods unless otherwise specified. The experimental materials used in the following examples were purchased from the market unless otherwise specified.

[0050] The chemiluminescence detection method for the curative effect of aspirin disclosed in this embodiment is to detect the content of 11-DH-TXB2 in human urine by chemiluminescence. The chemiluminescence method in this example adopts the principle of the competition method, uses magnetic particles as the solid phase of the immune reaction, and uses the chemilum...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a chemiluminiscence detection method and a chemiluminiscence detection kit for aspirin metabolism and platelet high reactivity. The kit comprises a monoclonal antibody combinedwith 11-dehydrothromboxane B2, a competitive product of 11-dehydrothromboxane B2, magnetic particles and a luminous substrate, wherein the monoclonal antibody is a mouse monoclonal antibody, the amino acid sequence of a light chain variable region of the mouse monoclonal antibody is shown as SEQ ID NO: 2 in a sequence table, and the amino acid sequence of a heavy chain variable region of the mouse monoclonal antibody is shown as SEQ ID NO: 4 in the sequence table. According to the present invention, with the application of the aspirin metabolism and platelet high-reactivity chemiluminiscencedetection method and the detection kit, whether the patient has aspirin drug resistance or resistance can be rapidly detected; the kit and the detection method provided by the invention have the advantages that the sensitivity is high, the accuracy is good, the kit and the detection method are not easily influenced by biochemical indexes, and the problem that the anti-platelet aggregation treatment of a clinical patient fails or the effect is poor due to aspirin resistance is solved.

Description

technical field [0001] The invention relates to a chemiluminescence detection method and a detection kit for aspirin metabolism and high platelet reactivity, belonging to the field of biological detection. Background technique [0002] 1. Metabolism of TXA2 and detection of 11dhTXB2 [0003] 11-dehydro-thromboxane B2 (11-dehydro-thromboxane B2, 11dhTXB2) is the terminal metabolite of thromboxane A2 (thromboxane A2, TXA2), which is mainly excreted by the kidneys, and is used in hemostasis and the occurrence of cardiovascular diseases. Play an important role. Prostaglandin H is produced from arachidonic acid by prostaglandin H synthase 1 and 2 (also known as COX-1 and COX-2). Prostaglandin H is chemically unstable and can be converted into a variety of biologically active prostaglandins under the action of isomerase, including TXA2, prostacyclin I2, prostaglandin D2, prostaglandin E2, and prostaglandin F2α. TXA2 is mainly synthesized in platelets through the COX-1 pathway. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N21/76G01N33/577
CPCG01N21/76G01N33/577
Inventor 李明勇
Owner 湖南远璟生物技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap